cetylpyridinium chloride anhydrous has been researched along with Peripheral Arterial Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thompson, B; Towler, DA | 1 |
Anzaldi, M; Fiore, V; Libra, M; Malaponte, G; Neri, S; Puccia, G; Signorelli, SS; Simili, M | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Peripheral Arterial Diseases
Article | Year |
---|---|
Arterial calcification and bone physiology: role of the bone-vascular axis.
Topics: Atherosclerosis; Blood Vessels; Bone and Bones; Health; Humans; Models, Biological; Peripheral Arterial Disease; Signal Transduction; Vascular Calcification | 2012 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Peripheral Arterial Diseases
Article | Year |
---|---|
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects.
Topics: Ankle Brachial Index; Biomarkers; Case-Control Studies; Demography; E-Selectin; Female; Health; Humans; Inflammation Mediators; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Peripheral Arterial Disease | 2012 |